Possible role of MDM2 , P53 and P21 gene polymorphism in the pathogesis of acute myeloid leukemia / Nermine Hassan Said Mohamed ; Supervised Khaled Mostafa Aboulenein , Iman Abdelmokhles Sedhom , Basma Mostafa Elgamal

By:

Nermine Hassan Said Mohamed

Contributor(s):

Material type: Text

TextLanguage: English Publication details: Cairo : Nermine Hassan Said Mohamed , 2012Description: 156P. : charts , facsimiles ; 25cmOther title:

الدور المحتمل للتعدد الشكلى الجينى ل MDM2 و P53 و P21 فى الإصابة بسرطان الدم الميلودى الحاد [Added title page title]

Subject(s):

Available additional physical forms:

Issued also as CD

Dissertation note: Thesis (Ph.D.) - Cairo University - National Cancer Institute - Department of Clinical Pathology Summary: MDM2 is a major negative regulator of P53 . P21 is a cell cycle checkoint gene functioning as a downstream effector of p53 . Gene polymorphisms have been implicated in cancer . The aim of this work is to study the frequency of MDM2 , P53 and P21 polymorphisms among AML patients referring to NCI and in apparently healthy controls

Tags from this library: No tags from this library for this title. Log in to add tags.

Average rating: 0.0 (0 votes)

Holdings
Item type	Current library	Home library	Call number	Copy number	Status	Date due	Barcode
Thesis	قاعة الرسائل الجامعية - الدور الاول	المكتبة المركزبة الجديدة - جامعة القاهرة	Cai01.19.03.Ph.D.2012.Ne.P (Browse shelf(Opens below))		Not for loan		01010110058353000
CD - Rom	مخـــزن الرســائل الجـــامعية - البدروم	المكتبة المركزبة الجديدة - جامعة القاهرة	Cai01.19.03.Ph.D.2012.Ne.P (Browse shelf(Opens below))	58353.CD	Not for loan		01020110058353000

Browsing المكتبة المركزبة الجديدة - جامعة القاهرة shelves Close shelf browser (Hides shelf browser)

Previous	No cover image available	No cover image available	No cover image available	No cover image available	No cover image available	No cover image available	No cover image available	Next
Previous	Cai01.19.03.Ph.D.2011.Yo.E Expression of chemokine [MCP-1] and chemokine receptors [CXCR4, CCR2] in acute myeloid leukemia /	Cai01.19.03.Ph.D.2012.Ab.M Molecular detection of cytokeratin - 19 mRNA positive cells in peripheral blood of breast cancer patients /	Cai01.19.03.Ph.D.2012.Ab.M Molecular detection of cytokeratin - 19 mRNA positive cells in peripheral blood of breast cancer patients /	Cai01.19.03.Ph.D.2012.Ne.P Possible role of MDM2 , P53 and P21 gene polymorphism in the pathogesis of acute myeloid leukemia /	Cai01.19.03.Ph.D.2012.Ne.P Possible role of MDM2 , P53 and P21 gene polymorphism in the pathogesis of acute myeloid leukemia /	Cai01.19.03.Ph.D.2012.No.P Prognostic value of BAALC gene and ERG gene in acute non lymphoblastic leukemia /	Cai01.19.03.Ph.D.2012.No.P Prognostic value of BAALC gene and ERG gene in acute non lymphoblastic leukemia /	Next

Thesis (Ph.D.) - Cairo University - National Cancer Institute - Department of Clinical Pathology

MDM2 is a major negative regulator of P53 . P21 is a cell cycle checkoint gene functioning as a downstream effector of p53 . Gene polymorphisms have been implicated in cancer . The aim of this work is to study the frequency of MDM2 , P53 and P21 polymorphisms among AML patients referring to NCI and in apparently healthy controls

Issued also as CD

There are no comments on this title.

to post a comment.